Skip to main content
Caplight Logo









G LNK

G LNK

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.glnkco.com/

Last Round

Accelerator

Mar 3, 2025

Total Funding Raised

$500,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

G LNK is a healthtech company that provides an AI-powered platform for pharmaceutical and life sciences organizations to identify and engage healthcare professionals compliantly.

Sector

Healthcare & Life Sciences

Verticals

Healthcare Analytics, Business Intelligence, Compliance & Risk, Vertical SaaS, Workflow Automation

Business Model

B2B

Customer Profile

Subscription SaaS, Data as a Service

AI Layer

Application

Keywords

healthcare intelligencelife sciences CRMHCP engagementfair market valueFMVhealthcare professional searchHCPpharma sales enablementvertical SaaScompliance automationcommercial intelligencepharma techAI sales copilotmarket intelligenceprescribing analyticsbiotech software

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

G LNK Comparables

Compare G LNK with similar companies based on industry and business-model similarity.

G LNK comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Alpha Sophia
83%
VEDA Data Solutions
81%
Forma Health
78%

G LNK Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorMar 3, 2025

G LNK Investors

Notable investors and investment history

G LNK investors
InvestorRounds
UCM VenturesSeed
Y CombinatorAccelerator
The E14 FundSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Monthly visitors increased 58% MoM.

  • Jun 20, 2026

    Monthly visitors increased 33% MoM.

G LNK Filings

Explore SEC and related filing metadata, where available.

G LNK filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about G LNK's valuation, stock price, and market status.

Is G LNK a public or private company?

G LNK is a private company.

What is the current stock price of G LNK?

G LNK is a private company, so its shares have no public market price. Caplight tracks G LNK's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is G LNK worth (valuation)?

Valuation information for G LNK is not publicly available.

Can I buy G LNK stock?

G LNK shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was G LNK's last funding round?

G LNK's most recent funding round was Accelerator on March 3, 2025.

Who are the main investors in G LNK?

Key investors in G LNK include UCM Ventures, Y Combinator, The E14 Fund.

Will G LNK IPO soon?

No public IPO plans have been announced for G LNK.

How can I track G LNK secondary market activity?

Caplight tracks bids, offers, and trades in G LNK's shares on secondary markets.

Firmographic Details

HeadquartersNew York City, New York
Employee Range13
Year Founded2024
Last FundingMar 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?